skinny.

Latest / Stock Movers

NatWest Rises, GSK Drops, Accor Up

On this episode of Stock Movers:

- NatWest raised its guidance for the year after beating estimates in the 3Q, delivering its highest earnings in at least a decade.

- GSK shares dropped as approval of the British pharma company’s blood cancer drug for a later-than-expected treatment line raised concerns about the medicine’s sales potential.

- Accor shares rose after 3Q earnings in which the hotelier raised its guidance on the back of improved cost discipline. It also announced a new €100 million buyback in 4Q.

See omnystudio.com/listener for privacy information.

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.